IMIC(SZ:000516) Sou Hu Cai Jing·2025-12-05 01:27Core Viewpoint - International Medical (000516) has experienced a decline in stock price and financial performance, indicating potential challenges in the healthcare service sector [1][3]. Financial Performance - As of December 4, 2025, the stock closed at 4.7 yuan, down 3.29%, with a trading volume of 225,400 shares and a turnover of 107 million yuan [1]. - For the first three quarters of 2025, the company's main revenue was 2.995 billion yuan, a year-on-year decrease of 16.94%, and the net profit attributable to shareholders was -294 million yuan, down 38.45% [3]. - The third quarter alone saw a main revenue of 961 million yuan, a decline of 18.95%, and a net profit of -129 million yuan, a significant drop of 234.24% [3]. Financing and Margin Trading - On December 4, 2025, the financing buy amounted to 13.736 million yuan, while financing repayment was 16.952 million yuan, resulting in a net repayment of 3.216 million yuan [2]. - The margin trading balance stood at 311 million yuan, with a short selling volume of 0 shares and a remaining short position of 10,000 shares [2]. Industry Comparison - The company's total market value is 10.523 billion yuan, significantly lower than the industry average of 18.125 billion yuan, ranking 43rd in the industry [3]. - The net asset value is 3.054 billion yuan, compared to the industry average of 5.861 billion yuan, also ranking 43rd [3]. - The company's gross margin is 6.59%, while the industry average is 36.47%, placing it 42nd in the industry [3]. Analyst Ratings - In the last 90 days, two institutions have given a rating of "buy" for the stock, with an average target price of 5.5 yuan [4].